Annual Current Ratio
51.59
+41.61+416.93%
December 31, 2023
Summary
- As of February 7, 2025, MLTX annual current ratio is 51.59, with the most recent change of +41.61 (+416.93%) on December 31, 2023.
- During the last 3 years, MLTX annual current ratio has risen by +51.13 (+11115.22%).
- MLTX annual current ratio is now at all-time high.
Performance
MLTX Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
25.51
-18.20-41.64%
September 30, 2024
Summary
- As of February 7, 2025, MLTX quarterly current ratio is 25.51, with the most recent change of -18.20 (-41.64%) on September 30, 2024.
- Over the past year, MLTX quarterly current ratio has dropped by -18.20 (-41.64%).
- MLTX quarterly current ratio is now -64.06% below its all-time high of 70.97, reached on June 30, 2023.
Performance
MLTX Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
MLTX Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +416.9% | -41.6% |
| 3 y3 years | +10000.0% | +5445.6% |
| 5 y5 years | +10000.0% | +5445.6% |
MLTX Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -64.1% | +5445.6% |
| 5 y | 5-year | at high | >+9999.0% | -64.1% | +5445.6% |
| alltime | all time | at high | >+9999.0% | -64.1% | +5445.6% |
MoonLake Immunotherapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 25.51(-41.6%) |
| Jun 2024 | - | 43.71(-29.6%) |
| Mar 2024 | - | 62.13(+20.4%) |
| Dec 2023 | 51.59 | 51.59(+6.3%) |
| Sep 2023 | - | 48.51(-31.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | 70.97(+676.5%) |
| Mar 2023 | - | 9.14(-8.4%) |
| Dec 2022 | 9.98(+2069.6%) | 9.98(-32.2%) |
| Sep 2022 | - | 14.71(-42.3%) |
| Jun 2022 | - | 25.51(+5445.7%) |
| Dec 2021 | 0.46 | 0.46 |
FAQ
- What is MoonLake Immunotherapeutics annual current ratio?
- What is the all time high annual current ratio for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual current ratio year-on-year change?
- What is MoonLake Immunotherapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly current ratio year-on-year change?
What is MoonLake Immunotherapeutics annual current ratio?
The current annual current ratio of MLTX is 51.59
What is the all time high annual current ratio for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual current ratio is 51.59
What is MoonLake Immunotherapeutics annual current ratio year-on-year change?
Over the past year, MLTX annual current ratio has changed by +41.61 (+416.93%)
What is MoonLake Immunotherapeutics quarterly current ratio?
The current quarterly current ratio of MLTX is 25.51
What is the all time high quarterly current ratio for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly current ratio is 70.97
What is MoonLake Immunotherapeutics quarterly current ratio year-on-year change?
Over the past year, MLTX quarterly current ratio has changed by -18.20 (-41.64%)